Literature DB >> 33191719

What do asthmatic patients think about telemedicine visits?

C Sabina Sousa1,2, M Trigueiro Barbosa1,3, R Aguiar1, F Benito-Garcia1, M Morais-Almeida1,4.   

Abstract

Summary: Introduction. Due to the Coronavirus disease 2019 (COVID-19) outbreak and the national emergency state, virtual visits were implemented as an alternative to in-person visits. With this study we aimed to establish asthma patients' general satisfaction with the quality of health care provided by virtual visits (phone or video calls). Materials and methods. A questionnaire (9 questions) was published on the Facebook page of the Portuguese Association of Asthmatics. It was available online for general self-reported asthmatic patients to answer during one month, starting on 11st May 2020. The survey only allowed one answer per registered user. Results. Fifty-five responses were obtained. Patients were satisfied with communication with providers (> 88%); nevertheless, one-half evaluated the virtual visit as inferior when compared to in-person visits. About one third attributed a classification of 6 or less (0-10 scale, 0 being the worst and 10 the best consultation possible), but still most of the patients would either recommend it or use this kind of medical visits in the future, even outside the actual pandemic context. Patients also referred some important limitations, as lack of physical examination and the fact that the medical visit was more impersonal. Only 27% had technical issues accessing virtual visits. Positive aspects were also named, such as virtual visits being practical and avoiding the need to move to the hospital. Discussion and conclusions. Our survey revealed that small changes could further increase patients' satisfaction, adherence and confidence in telemedicine. Although presenting some limitations, virtual visits seem to be generally well accepted by asthmatic patients and it might be a good alternative for in-person visits, at leastin such difficult times when social distancing is recommended.

Entities:  

Keywords:  Asthma; Asthma attack; IgE; biologics; eosinophils; registry

Year:  2020        PMID: 33191719     DOI: 10.23822/EurAnnACI.1764-1489.182

Source DB:  PubMed          Journal:  Eur Ann Allergy Clin Immunol        ISSN: 1764-1489


  6 in total

1.  COVID-19 pandemic impact on telehealth use and perceptions for atopic and respiratory disease: Survey results.

Authors:  Don A Bukstein; Jacqueline Eghrari-Sabet; Mary Hart; Tanisha Hill; Purvi Parikh; Tonya A Winders
Journal:  Allergy Asthma Proc       Date:  2022-05-01       Impact factor: 2.873

Review 2.  Shifts in Asthma Evaluation and Management During COVID-19.

Authors:  Connie H Lin; Daniel A Cerrone
Journal:  Curr Treat Options Allergy       Date:  2022-05-13

3.  The Perceptions of Telehealth Physiotherapy for People with Bronchiectasis during a Global Pandemic-A Qualitative Study.

Authors:  Annemarie L Lee; Louise Tilley; Susy Baenziger; Ryan Hoy; Ian Glaspole
Journal:  J Clin Med       Date:  2022-02-27       Impact factor: 4.241

4.  Transition to Virtual Asthma Care During the COVID-19 Pandemic: An Observational Study.

Authors:  Peter J Cvietusa; Glenn K Goodrich; John F Steiner; Jo Ann Shoup; Diane K King; Debra P Ritzwoller; Susan M Shetterly; Bruce G Bender
Journal:  J Allergy Clin Immunol Pract       Date:  2022-03-06

5.  European Respiratory Society statement on long COVID follow-up.

Authors:  Katerina M Antoniou; Eirini Vasarmidi; Anne-Marie Russell; Claire Andrejak; Bruno Crestani; Marion Delcroix; Anh Tuan Dinh-Xuan; Venerino Poletti; Nicola Sverzellati; Michele Vitacca; Martin Witzenrath; Thomy Tonia; Antonio Spanevello
Journal:  Eur Respir J       Date:  2022-08-04       Impact factor: 33.795

Review 6.  Using Telemedicine to Care for the Asthma Patient.

Authors:  Yudy K Persaud
Journal:  Curr Allergy Asthma Rep       Date:  2022-02-02       Impact factor: 4.919

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.